Pictures: SpaceX Crew-10 launches from Kennedy Space Center
The SpaceX Crew-10 mission launched from Kennedy Space Center on Friday sending a replacement crew to the International Space Station.
Riding in the Crew Dragon Endurance making its fourth trip to space were Crew-10 commander and NASA astronaut Anne McClain, fellow NASA astronaut and pilot Nichole Ayers, Japan Aerospace Exploration Agency astronaut Takuya Onishi and Roscosmos cosmonaut Kirill Peskov.
The launch marks the 16th human spaceflight for SpaceX's fleet of four Crew Dragon spacecraft, having now taken 60 people to space.
It was the 22nd launch on the Space Coast in 2025 and first with a crew.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
15 minutes ago
- Forbes
Exploration Leadership: NASA Astronaut On Boldness And Belonging
'If only people could see how connected we are, we'd know we could explore this world and others.' With this reflection, former NASA astronaut and retired U.S. Air Force Colonel Cady Coleman inspired an audience of 1,500 at The Chicago Network's Women in the Forefront luncheon. Coleman, a chemist, space scientist, veteran of two Space Shuttle missions and a six-month stint aboard the International Space Station, spoke not only about outer space, but about leadership, inclusion and determination here on Earth. Among her long list of accomplishments, Coleman is also author of 'Sharing Space: An Astronaut's Guide to Mission, Wonder and Making Change,' where she serves up insights on how to adapt, beat expectations and coalesce a disparate team. Although her experience is truly unique, she serves up universal leadership lessons. First and foremost, Coleman emphasized the value of connection. 'Build bridges,' she said. 'Find partners who don't do things the same way.' From collaborating with international teams aboard the ISS – including an Italian and a Russian, both men – to sharing a historic space-Earth flute duet with Ian Anderson of Jethro Tull, Coleman exemplifies how joy and curiosity can fuel exploration. The day's moderator Michelle Miller of CBS News added her perspective that 'we belong – to people, purpose and place.' It's up to each of us to foster that belonging. NASA Astronaut Cady Coleman NASA Coleman also shed light on the unseen barriers that prevent people from contributing fully. In training to become a spacewalker, a requirement for landing the International Space Station mission, she discovered NASA had eliminated size small and extra-large space suits to save money. The decision, while financially efficient, sidelined qualified astronauts, including women, whose bodies didn't fit the remaining sizes. In one meeting, a leader remarked, 'Don't worry, we will have enough spacewalkers,' implicitly accepting the exclusion of smaller-sized astronauts. Coleman didn't give up. She showed up at meetings where she wasn't invited, absorbing knowledge and demonstrating quiet resilience. If she had not persisted and learned how to train in the too-big space suit, her opportunity to serve on the Space Station would have been delayed by 11 years, she said. 'Put in the work,' she advised. 'So when things get tough, your training kicks in.' Coleman's stories weren't grim, they were energizing. She makes the struggle look joyful, not because it's easy, but because she chooses to lead with enthusiasm. That energy is contagious. In addition to her space-Earth flute collaboration, she showed clips of fellow astronauts playing baseball alone and photographing easily-recognized visuals like Cape Cod and the Great Lakes. Finding that joy expanded into positive and productive relationships with colleagues who were quite different from her. Throughout her talk, Coleman returned again and again to honoring her influences. She pointed to pioneers who didn't always get their due, including aviation trailblazer Bessie Coleman, who moved to France and learned a new language to get her pilot's license due to race and gender discrimination, and NASA mathematician Katherine Johnson, whose story was widely shared in the film Hidden Figures. Like them, Coleman's career reflects a quiet tenacity and a belief in showing others what's possible. The Chicago Network, whose membership includes the city's most influential women leaders, exemplifies Coleman's dedication to allyship, including for the younger set. During the Q&A portion of the event, several women stepped aside to let an eight-year-old girl ask the final question: 'How do you become an astronaut?' Coleman didn't talk about physics or math. She offered this: 'Let them know who you are. If they don't know who you are, people can't pick you.' She added that even something as humble as being a camp counselor signals leadership skills like logistics, patience, negotiation. Moderator Michelle Miller served up her own advice about seeking mentorship. She encouraged the young girl to follow up: 'Rush the stage and get Cady's contact info.'
Yahoo
3 hours ago
- Yahoo
Monster black hole jet from the early universe is basking in the 'afterglow' of the Big Bang
When you buy through links on our articles, Future and its syndication partners may earn a commission. Astronomers have captured a ghostly image of an ancient supermassive black hole shooting a giant energy jet into the early universe. The ethereal structure is only visible thanks to the "afterglow" of the Big Bang and a crucial NASA space telescope that could soon be prematurely switched off forever. The striking image shows the light of quasar J1610+1811, shining from around 11.6 billion light-years from Earth, during the "cosmic noon" — a period of the universe between 2 billion and 3 billion years after the Big Bang. Quasars are supermassive black holes that shoot out giant, lightsaber-like beams of energy perpendicular to their swirling accretion disks. However, until now, researchers have not had a proper look at J1610+1811's energy jet, despite discovering the object back in 2018. The new image was captured with NASA's Chandra X-ray Observatory, which is fine-tuned to hunt some of the most powerful wavelengths of the electromagnetic spectrum. The research was uploaded to the preprint server arXiv on April 13 and has been accepted for future publication in The Astrophysical Journal. The researchers also presented their findings at the 246th meeting of the American Astronomical Society, held between June 8 and 12 in Anchorage, Alaska. Using the new image as a guideline, the team calculated that the quasar's jet is more than 300,000 light-years long, which is around three times wider than the Milky Way. High-energy particles within the jet are also likely shooting from the black hole at between 92% and 98% the speed of light. "The jet from J1610+1811 is remarkably powerful, carrying roughly half as much energy as the intense light from hot gas orbiting the black hole," which is among the fastest and hottest matter in the universe, NASA representatives wrote in a statement. Related: Behold the first direct image of a supermassive black hole spewing a jet of particles Despite their immense power, jets like J1610+1811's are hard to detect because they are often pointed away from Earth, which makes them appear much dimmer thanks to special relativity. However, Chandra could see this jet because it is "being illuminated by the leftover glow from the Big Bang itself," NASA representatives wrote. This afterglow is the cosmic microwave background (CMB), leftover radiation from just after the cosmos-birthing explosion that permeates the entire universe. During cosmic noon, the CMB was much more dense than the version we can currently detect from Earth, which is what creates the static heard on radios and seen on old televisions. As electrons from the black hole's jets shoot toward Earth, they collide with photons within the CMB and accelerate these light particles to become X-rays, which can be spotted by Chandra. Without the high density of the CMB during this period, the quasar would not have shone in X-ray light and the image would not have been possible. During the study, the researchers captured less-detailed images of another quasar, J1405+0415, which is also shining at us from the cosmic noon. The new findings could help shed light on why quasars and other supermassive black holes grew faster and larger during this period than at any other point in the universe's history. Chandra was launched in July 1999 and has since revolutionized X-ray astronomy. Today, it is still making new discoveries, including a fracture in a "cosmic bone" and never-before-seen types of pulsars. However, despite having an estimated 10 years of operational lifespan remaining, the space telescope's future is in doubt, due to some NASA funding problems in 2024 and the Trump administration's proposed budget cuts for 2026, which would be the largest in the agency's history. If the latest cuts are approved, Chandra will likely be switched off permanently. The loss of Chandra would be equivalent to an "extinction-level event" for X-ray astronomy in the United States, according to the website RELATED STORIES —Biggest black hole jets ever seen are as long as 140 Milky Ways —Scientists make lab-grown black hole jets —'Very rare' black hole energy jet discovered tearing through a spiral galaxy shaped like our own "I'm horrified by the prospect of Chandra being shut down prematurely," Andrew Fabian, an X-ray astronomer at the University of Cambridge, told Science magazine in 2024. "If you start doing deep cuts so abruptly, you will lose a whole generation [of X-ray astronomers]," Elisa Costantini, an astronomer at the Netherlands Institute for Space Research, added in an interview with Science. It will leave "a hole in our knowledge" of high-energy astrophysics, she said.
Yahoo
3 hours ago
- Yahoo
Could the answers to cancer lie in space? Why off-Earth research is heating up
When you buy through links on our articles, Future and its syndication partners may earn a commission. There's a good reason why astronauts tend not to stay on the International Space Station longer than six months: Microgravity is not kind to human bodies. Among other effects, it can flatten eyeballs and swell up fingers and faces, causing blinding headaches as blood, organs and cells react in ways they wouldn't on Earth. For the same reasons, though, space may be the perfect place to study cancer — and someday even treat it. This year, tumors grown in laboratories on Earth are headed to the ISS as part of the first research project to use artificial organs for cancer testing in space. Scientists at Wake Forest University are working to develop cancer-screening tests that are faster and more sensitive. But the greater significance of their experiment may be as a trial run for a raft of other biomedical projects planned for low-gravity environments that spur cell growth. "Microgravity is an accelerator of conditions. Every disease, every phenotype — everything we want to study can happen faster in less time," says Davide Marotta, program director for In-Space Biomanufacturing at the ISS National Laboratory. "Instead of waiting 10 months, you can go up [to space] in 10 days" to see the same biological effects, he adds. On Earth, gravity slows the development of cancer because cells normally need to be attached to a surface in order to function and grow. But in space, cancer cell clusters can expand in all directions as bubbles, like budding yeast or grapes, said Shay Soker, chief science program officer at Wake Forest's Institute for Regenerative Medicine. Since bubbles grow larger and more quickly in space, researchers can more easily test substances clinging to the edge of the larger bubbles, too. Scientists at the University of Notre Dame are taking advantage of this quirk to develop an in-space cancer test that needs just a single drop of blood. The work builds on a series of bubble-formation experiments that have already been conducted on the ISS. "If cancer screening using our bubble technology in space is democratized and made inexpensive, many more cancers can be screened, and everyone can benefit," said Tengfei Luo, a Notre Dame researcher who pioneered the technology, speaking to the ISS' magazine, Upward. "It's something we may be able to integrate into annual exams. It sounds far-fetched, but it's achievable." Protecting astronauts from the health risks of space travel is another key priority for biomedical researchers working with NASA. On the ISS and other space missions, astronauts not only have to deal with all of the physiological changes associated with microgravity, but also the dangers of cosmic radiation, which can mutate DNA in human cells. Astronaut Frank Rubio holds the NASA record for the longest continuous time spent in space at 371 days, with Russian cosmonaut Valeri Polyakov holding the overall record with 437 consecutive days — a venture he volunteered for to prove humans could survive the time it would take to travel to and from Mars. But NASA's general rule is that astronauts should try to minimize their time in orbit to reduce health risks. "For astronauts returning to Earth, they have difficulty just moving around," said Ben Soares, who studies space medicine at Boston University. "Even sitting in a chair involves muscles. Everything just falls apart when you don't use it." A study of astronaut twins Scott and Mark Kelly found that Scott aged faster than his brother, who remained on Earth while Scott was in space. Microgravity also altered Scott's genetics, switching certain genes on or off. Cancer risks are likely higher for astronauts, too, and not only because radiation can cause mutations in DNA. Cell membranes are held up by small proteins called microtubules that keep the cell's shape rigid, but when the gravitational force changes — even though gravity on the ISS is only 10% weaker than on Earth — the cell's structure changes with it. On Earth, microtubule spindles ensure that a cell's chromosome replicates the structure. But microgravity distorts microtubules and can lead to irregular cell division, making cancer more likely. "You may think [astronauts] are just floating around in space, but all those microtubules, and the major deformations in the outer membranes, change rapidly when there's microgravity exposure," said Soares. "People are wondering more and more whether changes are happening at an actual genetic level." Again, though, these genetic effects also create unique opportunities for researchers seeking new diagnostic tests and treatments. For example, if scientists can pinpoint which genes are switched off in microgravity, then they might be able to activate them or deactivate them artificially for cancer patients on Earth. Pharmaceutical research could benefit, too. In orbit, drug companies could drastically speed up a review and testing process that usually takes many years before the Food and Drug Administration approves the treatment. As the cost of in-orbit testing falls, it could become a key way to quickly evaluate all sorts of medications without having to spend years waiting to see if they work on diverse populations, according to the ISS National Laboratory's Marotta. "Every person has a different response to the same drug," Marotta said. "We have drug resistance, failure of therapies, etc. Meanwhile, space costs will be lower and lower in the future." Chemotherapy patients could save precious time, too. In normal gravity, they typically have to spend a half-hour hooked up to a needle before the medicine begins to take effect, because most drugs don't dissolve easily in water. But scientists at Merck have discovered that, in space, their widely used cancer drug pembrolizumab, or Keytruda, can be administered through a simple injection, because large crystalline molecules that would normally clump together are suspended in microgravity. So far, though, Merck hasn't been able to find a way to administer its drug via injection on Earth. Similarly, the blood test developed by Notre Dame researchers only works in space, with no ability yet to simulate low gravity effectively here on Earth. These limitations raise the question of whether patients might someday be treated in space to take advantage of lower gravity. It's not a completely far-fetched idea, according to Soker, though he acknowledged that it is prohibitively expensive for now. The ISS currently houses just seven astronauts, and SpaceX apparently charges space tourists approximately $55 million for a three- to eight-day trip into low Earth orbit. The hope is that those costs will come down drastically in the future. Related Stories: — How can space travel lead to medical breakthroughs? Veteran astronaut explains — 'Them space drugs cooked real good:' Varda Space just made an HIV medicine in Earth orbit — Can we live long and prosper in space? The astronaut health dilemma The next big step, according to Soker, would be an orbiting facility dedicated to researching treatments for cancer and other debilitating conditions. "Maybe we can actually figure out which patients are the ones who are going to benefit from the space environment," he says. "If you're going to put several million dollars [into cancer treatment], I mean, you need to actually be sure that this is going to be helpful for you." Someday, microgravity could even help patients recovering from surgery heal faster than they would on Earth, Soker added. "Wound healing in high pressure is faster. That's the hyperbaric treatment for wounds." Before they can dream of a new generation of orbiting laboratories, though, researchers are under pressure to make the most of the one they have now — but won't be able to use for much longer. The ISS is set for destruction in 2031, after more than three decades in orbit, giving scientists only a handful of additional years to conduct their tests in the hopes of medical breakthroughs. "It's run its course," says Soker. The key task now, he said, is for teams like his to deliver practical research results that could unlock funding for the next phase of biomedical research in space. Researchers are already benefiting from a recent increase in support thanks to the U.S. government's Cancer Moonshot Initiative, which funnels research dollars into techniques to help Earth-bound patients as well as astronauts. For the Wake Forest experiment, which is scheduled to launch next spring, scientists will cut out two sections of a cancer tumor from around 20 patients. One sample will stay on Earth while the other heads to the ISS, with scientists observing the difference. The testing will be completed within a week, to avoid any interference from cosmic radiation. If successful, Soker said, it could set the stage for diagnostic cancer tests in space available to the general population — perhaps on a biomedical space station that could launch after the planned demise of the ISS. "Can we actually design a special cancer space station that will be dedicated to cancer and maybe other diseases?" Shoker asked, answering his question in the affirmative. "Pharmaceutical companies that have deep pockets would certainly support that program."
